|
Sotac Pharmaceuticals Ltd
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
104.86 Cr.
|
P/BV
|
1.78
|
Book Value (Rs.)
|
53.28
|
|
52 Week High/Low (Rs.)
|
140/86
|
FV/ML
|
10/1200
|
P/E(X)
|
16.66
|
|
Bookclosure
|
19/09/2025
|
EPS (Rs.)
|
5.70
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 77.39 |
| Total Income From Operations | 77.39 |
| | |
| EXPENDITURE | |
| Consumption of Raw Materials | 56.81 |
| Purchase of Traded Goods | 1.73 |
| Increase/Decrease in Stocks | -0.45 |
| Employees Cost | 2.81 |
| Depreciation | 2.22 |
| Other Expenses | 9.15 |
| Total Expenses | 72.26 |
| | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 5.12 |
| Other Income | 0.67 |
| P/L Before Interest, Excpt. Items & Tax | 5.79 |
| Interest | 1.89 |
| P/L Before Exceptional Items & Tax | 3.90 |
| Exceptional Items | -0.23 |
| P/L Before Tax | 3.66 |
| Tax | 1.59 |
| P/L After Tax from Ordinary Activities | 2.07 |
| Net Profit/Loss For the Period | 2.07 |
| Minority Interest | 0.57 |
| Net P/L After Minority Interest & Share Of Associates | 2.64 |
| | |
| Equity Share Capital | 11.05 |
| EPS Before Extra Ordinary * | |
| Basic EPS (Rs.) | 2.41 |
| Diluted EPS (Rs.) | 2.41 |
| EPS After Extra Ordinary * | |
| Basic EPS (Rs.) | 2.41 |
| Diluted EPS (Rs.) | 2.41 |
| | |
| PBITOE Margin (%) | 6.61 |
| PBTE Margin (%) | 5.03 |
| PBT Margin (%) | 4.73 |
| PAT Margin (%) | 2.67 |
| PAT After MI And SOA Margin (%) | 3.40 |
